Wockhardt is currently trading at Rs. 434.70, up by 12.65 points or 3.00% from its previous closing of Rs. 422.05 on the BSE.
The scrip opened at Rs. 431.40 and has touched a high and low of Rs. 443.00 and Rs. 431.00 respectively. So far 193270 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 852.55 on 30-Apr-2018 and a 52 week low of Rs. 375.00 on 14-Feb-2019.
Last one week high and low of the scrip stood at Rs. 443.00 and Rs. 413.00 respectively. The current market cap of the company is Rs. 4831.45 crore.
The promoters holding in the company stood at 74.07%, while Institutions and Non-Institutions held 8.55% and 17.38% respectively.
Wockhardt has incorporated wholly owned subsidiary namely ‘Wockhardt Medicines’ (WML) with effect from March 25, 2019. The main object of WML is pharmaceuticals business is to carry on either as manufacturers, processors, traders, dealers, exporters, importers warehousing agents, commission agents etc.
The WML is incorporated with an Authorised Share Capital of Rs 10 lakh. The Company has subscribed to 100% shareholding comprising of 50,000 equity shares of Rs 10 each i.e. Rs 5 lakh in WML.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1817.60 |
Dr. Reddys Lab | 1351.25 |
Cipla | 1475.90 |
Lupin | 2168.30 |
Zydus Lifesciences | 964.40 |
View more.. |